Human growth is a dynamic process that needs careful documentation. It is recommended to refer individual growth to a reference population, and to transform and plot individual measurements into percentiles or standard deviation score (SDS) scales. A certain amount of percentile or SDS crossing is a physiological phenomenon that occurs at all ages and relates to the individual changes in developmental tempo. Between early childhood and adulthood, two thirds of all children and adolescents cross >1 SD in height. Particularly during pubertal age, SDS crossings can lead to several characteristic patterns such as sharp downward or upward SDS peaks. Upward SDS peaks indicate faster than average tempo, downward SDS peaks indicate slower than average tempo. Almost half of the pubertal height variation consists of variation in tempo. Applying functional data analysis and principal component analysis, the two main sources of height variance, i.e. tempo and amplitude, can be statistically separated and quantified. This review aims to renew some of the old debates on how to assess growth, and to facilitate forthcoming consensus upon how to appropriately evaluate height and changes in height at brief and clinically relevant intervals.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.